Cases & Deals

  • Home
  • Practices
  • Abbott and TAP Pharmaceutical settle NJ class action claiming violations of Prescription Drug Marketing Act in pricing Lupron®

Share

Abbott and TAP Pharmaceutical settle NJ class action claiming violations of Prescription Drug Marketing Act in pricing Lupron®

December 2007

Client(s) Abbott Laboratories and TAP Pharmaceutical Products Inc.

Jones Day represented Abbott Laboratories and TAP Pharmaceutical Products, Inc. in the defense of a New Jersey statewide class action alleging fraud, common law fraud and conspiracy in the pricing of its prostate cancer drug Lupron®.

Walker v. TAP Pharmaceutical Products et al. (N.J. Sup. Ct.)

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.